These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11487274)

  • 1. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
    Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
    Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
    Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma.
    Wang M; Zhu XY; Wang L; Lin Y
    Cancer Biother Radiopharm; 2015 Apr; 30(3):139-45. PubMed ID: 25775393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
    Wu W; Fan YH; Kemp BL; Walsh G; Mao L
    Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
    Miyata H; Doki Y; Shiozaki H; Inoue M; Yano M; Fujiwara Y; Yamamoto H; Nishioka K; Kishi K; Monden M
    Clin Cancer Res; 2000 Dec; 6(12):4859-65. PubMed ID: 11156245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
    Singh L; Pushker N; Sen S; Singh MK; Bakhshi S; Chawla B; Kashyap S
    Br J Ophthalmol; 2015 Apr; 99(4):457-63. PubMed ID: 25326518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CDC25A and CDC25B in head and neck cancers.
    Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
    Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CDC25B expression in gliomas.
    Nakabayashi H; Hara M; Shimizu K
    J Clin Pathol; 2006 Jul; 59(7):725-8. PubMed ID: 16803948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
    Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
    BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma.
    Takemasa I; Yamamoto H; Sekimoto M; Ohue M; Noura S; Miyake Y; Matsumoto T; Aihara T; Tomita N; Tamaki Y; Sakita I; Kikkawa N; Matsuura N; Shiozaki H; Monden M
    Cancer Res; 2000 Jun; 60(11):3043-50. PubMed ID: 10850455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Aug; 7(8):2213-21. PubMed ID: 11489794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas.
    Hernández S; Hernández L; Bea S; Pinyol M; Nayach I; Bellosillo B; Nadal A; Ferrer A; Fernández PL; Montserrat E; Cardesa A; Campo E
    Int J Cancer; 2000 Mar; 89(2):148-52. PubMed ID: 10754492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
    Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
    Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases.
    Ferguson AM; White LS; Donovan PJ; Piwnica-Worms H
    Mol Cell Biol; 2005 Apr; 25(7):2853-60. PubMed ID: 15767688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
    Kudo Y; Yasui W; Ue T; Yamamoto S; Yokozaki H; Nikai H; Tahara E
    Jpn J Cancer Res; 1997 Oct; 88(10):947-52. PubMed ID: 9414655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M; Kaibara N
    Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.
    Broggini M; Buraggi G; Brenna A; Riva L; Codegoni AM; Torri V; Lissoni AA; Mangioni C; D'Incalci M
    Anticancer Res; 2000; 20(6C):4835-40. PubMed ID: 11205229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy.
    Sunada F; Itabashi M; Ohkura H; Okumura T
    World J Gastroenterol; 2005 Sep; 11(36):5696-700. PubMed ID: 16237768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China.
    Shou JZ; Hu N; Takikita M; Roth MJ; Johnson LL; Giffen C; Wang QH; Wang C; Wang Y; Su H; Kong LH; Emmert-Buck MR; Goldstein AM; Hewitt SM; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1424-35. PubMed ID: 18559558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Nakamura Y; Kakudo K; Miyauchi A
    Cancer Lett; 2005 Nov; 229(2):291-7. PubMed ID: 16095809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.